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INTRODUCTION
A 11st of drugs used by the average physician

of today would be revealing by the number, variety
and duplications.

But no Doctor would be willing

to surrender opium in some form.

No adequate sub-

stitute has been found to date, but probably the
nearest approach was made when Demerol was placed
at the disposal or the profession in 1939.
Since that time, numerous investigators,
clinicians, and drug firms have tested the new drug
both in the laboratory and on clinical patients.
Although the drug is not in general use at the

~

present time, more and more members of tne profession are using it~

From time to time more litera-

ture will be written on Demerol, which at present
is still small in amount.

Since most Demerol is

going to the armed forces, it has become increasingly difficult to obtain, further hindering investigation.
The striking similarity of the action of
Demerol to that of morphine on the central nervous
system so far as analgesia and sedation are concerned, led us to the belief that the drug could
be used in place of morphine.
~

'-'

I

The increasing need

~

for l!lorphine in the time

or

war and the present

threat to our op1um supply, make it important
tilat appropriate consideration be given to t.au.s
new an~~gesic, Demerol.

This compound can be

prepared synthetically trom available onemioals,
and according to 1ta p1oneer cl1n1cal investigators ranks "runner-up" to morphine in relievlng pa1n.

While morphine is dangerous

both.

in

tox1c1ty and addition, Demerol 1s relat1vely safe.
Demerol was or1g1nally intended as a safe
analgesic ror hopeless, bed-ridden sut't"erers of
Its rapid excretion and its non-accum'1la-

pain.

"-'

t1on in the tissues, however, render 1t ideal tor
ambulant patients with r~lativ~ly constant paiDa.
Demerol will prove a blessing to wounded 5oldiers,
.-ho no longer will nc;ed to"gr1n and bear it" lest
relieving opiates lead to addic~ion.
Bot having tne opportunity to

St;e

Demerol in

action on clinical patients, I shall attempt to
review the available literature on Demerol and
evaluate its effectiveness with espec1al ret"erence

to its, chemistry,pharmacology, cl1n1cal uses and
safety.

Comparisons with morphine will be made

wherever possible.

'--
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CHEMISTRY

In 1939, E1sleb e.nd Schaumann introduced a
new synthetic, phenylpiperidine derivative,
Demerol, which was found to possess properties
similar to those of atropine and morphine.

It

was discovered in the course of a search for compounds having spasmolytic properties of the atropine series of drugs.

The patent rights were

purchased by a United States drug manufacturer
just before the outbreak of World War II.
Demerol is ethyl l-methyl-4-phenylpiperidine4-earboxylate and has the following structural

"-'

formula:

N-cu 3

c-.Ms C-COOC1.Ms

I
l

H~,1CM2

~ 2
I

M~
..

CH 2

w'1cvc.1,,1,.

>-

~

~H2.'
I

N

1-l

C~J

DeL.,,::r·ol

OM

Comparing its structural formula. with that of
morphine it is noted that little similarity exists
between the two drugs.

Upon rearrangement of the

ethenemine chain of the morpnine nucleus, a piperidine ring becomes evident.

However, Demerol

is lacking the phenolic and alcoholic hydroxyl

"'-'
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groups attached to the phenanthrene nucleus to
which the properties of morphine have been attributed.

However, its chemical similarity to mor-

phine particularly the piperidine ring about
which Demerol was built has been detected.

It has

been known for years that piperidine compounds
were analges1e and thau uie esters of basic alcohols were spasmolytic.

In comparison with popular analgesics, such
drugs as the salicylates, acetanilid, and amidopyrine may be dismissed.

They are somewhat spe-

cific in the types of pains affected.

"-'

Furthermore,

their analgesic strength is but a fraction of that
possessed by Demerol.
Of the opium alkaloids, codeines analgesic
index ranks far below Demerol.

Pantopon, dilaudid,

and papaverine rank higher but are considerably

less effective than Demerol.

Morphine turns up as

the only practical analgesic that rivals Demerol.
Demerol is not an opiate derivative.

It is

a white crystalline substance, slightly soluble in

water and with a strong alkaline reaction.

For

medicinal purposes the hydrochloride is employed;
this is also a colorless crystalline powder with

--..
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'-\a melting point of from 185 to 187°

c.

It is

readily soluble in water, has a neutral reaction
and a slightly bitter taste.

The solution is not

decomposed by short periods of boiling.
PHARMACOLOGY
Demerol hydrochloride possesses not only a
spasmolytic action common to the esters of basic
alcohols, but also analgesic properties greater
than ever before observed with synthetic compounds
considered suitable for clinical usev

It has a

distinct spasmolytic (relaxing) action on the

~

smooth muscle of the gut, the uterus, the bronchial tree and the urinary bladder.

This action is

due in part to a depression of the para-sympathetic
endings, but is primarily the result of a direct
depressant effect on the muscles, and although
more effective is comparable in this respect to
the action of papaverine.
R.

v.

Christie (9) states that Demerol will

antagonize the effect of acetylcholine and of
histamine on the gut.

The effect of pilocarpine

and physostigmine on the intestinal segment can
be completely or temporarily abolished by the

'--~
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addition of an adequate amount ot Demerol hydrochloride.

The effect of Demerol in this respect

is less than that of atropine.
When the isolated frog heart is perfused in
situ as described by Barlow and Sollmann (3),
Demerol in dilutions of 1:200,000 or less produces
a slight depression in amplitude and tone.

Con-

centrations of 1:25,000 or more produce a heart
block.

With short perfus1ons the block is re-

versible.

The depressant effects of high dilutions

of Demerol are largely antagonized by atropine. In
dilutions of from 1:5000 to 1:50,000, Demerol

~

renders the cardiac vagus of the frog progressively less responsive and finally non-responsive to
electric stimuli.

The vagal threshold of the

anesthetized dog is similarly affected by intravenous dosages of this compound.
The action of Demerol on the heart seems to
be one of vagal depression superimposed on a
primary muscular depression.

The cardiac sym-

pathetic is likewise depressed but this effect
develops more slowly and recovery therefore occurs
more rapidly than from the parasympathetic effect.
Bronchial spasm induced in guinea pigs by

..,

'--
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~
exposing them to a mist of histamine in a closed
chamber can be prevented if Demerol is injected
prophylactically.

Doses of 10 mg. per kg. of

body weight subcutaneously become effective within five minutes or less and the effects persist
for about an hour.

With larger doses the effects

last for from two to three hours.
Demerol hydrochloride injected subcutaneously in cats in a dose of 3 mg. per kg. of body
weight produces a definite enlargement of the
pupil.

If applied directly to the eye in a 1 per

cent solution, slight dilatation of the pupil is
'~

observed.

Therapeutic doses in man administered

either by mouth or parenterally cause little if
any change in the size of the pupil.
Demerol hydrochloride in doses of ~O mg. per
kg. injected subcutaneously in cats produces a
marked diminution of salivary flow.

However,

this effect is considerably less than that which
is produced by O.l mg. per kg. of atropine.

The

blood supply of the kidneys can be greatly decreased by the administration of epinephrine and
related vasoconstrictorsa

The constriction of the

renal vessels may be counteracted entirely by

"'-
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appropriate doses of Demerol.

Atropine in the

same dosage is without effect.
Demerol hydrochloride has little if any
effect upon blood sugar.

Following doses up to

10 mg. per kg. subcutaneously, the blood sugar
level of fasting albino rabbits varies within
normal limits, and doses of 20 mg. per kg. increase it but slightly.
The results by Gruber, Hart and Gruber (16)
from experiments carried out in dogs are somewhat
different from these cited above.

They found

that the effects of Demerol on smooth muscle

~

(intestine, bronchus, uterus, and blood vessels)
is unpredictable.

If the muscle is relaxed, the

drug usually causes some contraction, while if it
is contracted, relaxation is often seen.

On

intact smooth muscle (s1-0macn, pyloric sphinctwr,
am.all 1ntes~1ne and urinary bladdorJ the drug
sh0<1tS

n.v promise of value as a spasmolytic agent;

contractions of the muscle occur.

'I'he value must

be therefore, attributed to its analgesic potency.
On intact and excised uteri, it was found th~t
this chemical was of no value as a uterine sedative.

' '-

The stimulant action, which is a most

6
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common finding is much less potent than that of
pituatrin.
Demerol hydrochloride is broken down very
rapidly after oral or parenteral administration
to the intact animal.

The rapidity of the break-

down makes it difficult to trace the components
of the drug.

Only in extremely toxic doses is

the presence of the drug demonstrated in the urine.
It is thought to be broken down by the liver and
to a much lessor extent by the tissues of the
central nervous system.

The rapidity of destruc-

tion of the drug in vivo may account for the re-

"-'

latively short period of analgesia, the small
amounts of the drug detectable in the urine and
the ability to administer the drug prolonged
periods at intervals of three to four hours without cumulation of toxicity.

"'7

-~
TOXICITY AND TOLERANCE
Demerol hydrochloride has been found to be
relatively non-toxic.

Eisleb and Schaumann {13)

report the minimum lethal dose of Demerol for
mice as 150 mg. per kg. subcutaneously and 60 mg.
per kg. intravenously; for rabbits 30 mg. per kg.
intravenously and 700 mg. per kg. orally.

On the

basis of his observations, Gruber (16) reported
the lethal dose per kg. of Demerol to be as
follows:

For white mice, 147 mg. intraperitoneally

and 221 mg. orally; for albino rats, 93 mg. intraperitoneally; and for rabbits weighing from 2.3

"'-

to 4.2 kg., 20 mg. intravenously.
The oral administration of Demerol to cats in
doses up to 75 mg. per kg. produces a marked analgesic effect with little depression.

Doses of

100 mg. per kg. or more produce excitement and
clonic convulsions.

Although there are a number

of similarities between the action of Demerol and
that of morphine, there is a striking difference
between these drugs so far as their action on the
cat is concerned.

The wild or senseless random

movements which characterize the action of morphine in cats are not seen following the ad.minis-

~
8

·~

tration of Demerol.

On the other hand, Demerol

produces a quiet, mildly depressed analgesic
state.

In dogs intravenous administration of doses
of 5 mg. per kg. produce no significant effect.
Larger doses produce excitement, and excessive
doses may be associated with clonic convulsions.
Following intramuscular administration of doses
of 20 mg. per kg., dogs exhibit an increase in
salivation and slight ataxia.

With doses of from

30 to 50 mg. per kg., the ataxia is associated
with marked spastioity, sluggish random movements

"'-

and olonic convulsions.
Chronic administration of Demerol in a dose
of 75 mg. per kg. to 8 adult dogs and 40 mg. per
kg. a day to 24 monkeys was continued for a period
of ten months.

Although a slight degree of ano-

rexia and a slight falling off in weight were observed, no deleterious effect was produced with respect to the hematopoietic system; upon necropsy
no histologic changes in the liver, kidneys, spleen,
gastric mucosa, or bone marrow were noted.

In an-

other experiment which consisted of daily intramuscular administrations of Demerol at eight hour
\..

~
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intervals for twenty-eight days in a similar

dosage, there was no organic evidence of toxicity, but only apathy, spasticity and ataxia,
hypersalivation and depression.

The metabolism

of these animals remained unaltered.
Gruber (16) studied the effect of excessive
doses of Demerol on the hematopoietic system in
dogs by administering the drug in doses of from
50 to 100 mg. per kg. per day for a period of
seven weeks.

At no time during the entire seven

weeks was the blood picture of any animal significantly different from the control.

'-\..;

It has also been found the Demerol has no
effect on the hematopoietic system or blood
picture of the rabbit when given in doses up to
20 per cent of the M.L.D. daily (by intramuscular
injection) over a period of thirty days whether
•

to normal rabbits or to animals poisoned chronically with aminopyrine.
Batterman (5) found Demerol to be safe and
with the exception of certain side effects is nontoxic in therapeutic doses.

These side effects

are usually insignificant, are of brief duration
and do not as a rule inconvenience the patient to

'--

~
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any appreciable degree.

Their occurrence is un-

predictable, since they may appear after the first
dose or only occasionally after several doses.

The

sex, age and weight of the patient, the diagnosis
and the accompanying conditions do not have any
relation to the type, frequency and severity of
the side effects •

.After prolonged administration

they occur with less frequency, may decrease in
their intensity or may subside completely.

It is

not unusual for a rapid tolerance to the unpleasant reactions to develop and yet the patient may
obtain an equal or even better relief of the pain.

~

This tolerance varies for the individual subject.
J..ny discussion of tolerance must take into

account the various effects that can be produced
with Demerol.

Repeated doses of morphine result

in the development of tolerance to the depressant
effects on the central nervous system, such as
sedation, analgesia and respiratory depression.

In the case of Demerol, tolerance to the skin pain
threshold raising effect is usually manifest within two wee£s md raac~'1;;,s a. maximum at the end of
eight weeks.

In a group of 115 hospitalized

patients receiving from 42 to 492 doses

~
11

or

Demerol

·~

within periods of from four to twenty-eight weeks
no appreciable tolerance to its general clinical
analgesic effect occurred.

Clinical analgesia

is probably the result of one or more of the following effects: (1) a central action on the midbrain or the thalamic area blocking or reducing
the transmission of pain sensation from the periphery to the cerebral cortex, (2) an altered
reactivity of the patient to the pain, so that
even if perceived the 'fear reaction' is not
evoked and (3) an increased threshold to painful
stimuli at the periphery.

~

The latter factor, al-

though of immense help in evaluating relative
potency of analgesics, appears to be of minor importance as far as general analgesia is concerned.
One should avoid repeated large doses of
either Demerol or morphine because of cumulative
toxicity.

In the case of Demerol, this may take

the form of cerebral irritation or convulsions,
while cerebral depression with marked respiratory
difficulty is the rule with morphine.

Convulsive

seizures have occurred with Demerol if the dose
exceeds 200 mg. every 2 hours.

This has been

particularly noted in previous opiate addicts who

~
12
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abuse Demerol as a substitute drug.

It has never

been noted with therapeutic doses, although minimal signs such as tremors and uncoordinated muscular movements may occur in an occasional patient.
This represents and indication for decreasing the
dose or discontinuation of the drug.
With the exception of cerebral irritability
with large doses, Demerol is relatively a safe
drug.

Prolonged use has not resulted in alteration

of the hematopoietic system or produced disturbances in liver or kidney function.

In contrast to

morphine it may be used freely in patients with

~

liver or kidney disease.

To date no disease or

other medication including the sulfonamide drugs
has been found incompatible with Demerol.
R. C. Batterman (6) found significant side reactions in about 25 per cent of hospitalized or
bedridden patients receiving the drug parenterally.

These reactions are usually of minor import-

ance and do not as a rule inconvenience the patient
to any appreciable degree.

The commonest reaction

is dizziness which occurs in approximately 22 per
cent of the patients.

Unless associated with

other reactions it is not very disturbing and with

""'-'
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repeated use of the drug may diminish or subside
completely.

Nausea and vomiting was noted in

approximately 4 and 8 per cent respectively.
These also subside promptly if the drug is continued.

The incidence is much lower than that

noted with morphine.

Perspiration and dryness of

the mouth may at times be marked.
With exception of perspiration, all these

reactions occur with a higher incidence and severity in ambulatory patients.

Thus dizziness is

noted in 59 per cent of the patients, nausea in
26 per cent and vomiting in 12 per cent.

~

Toler-

ance to the unpleasant reactions usually occurs
with prolonged use but the majority of patients
may experience mild side effects with each dose
for several weeks or months.

Of particular import-

ance is the occurrence of weakness and syncope
that are noted only in ambulatory patients. Since
Demerol possesses vasodilating properties, the
compensatory mechanisms necessary to maintain the
circulation in the upright posture may be temporarily overcome.

If the patient is advised to seek

a recumbent position as soon as wea'kness is noted

the reaction may be aborted

'-'-'
14

,Yr'

d0creas =d in sev;;:,r-

~

-

~ty. Because

or th~ nigher incidence of reactions

and the possibility of syncope, the drug should

be used with caution in the ambulatory patient.

It may be necessary to determine for each patient
the optimum dose required for therapeutic effects
and to reach this dose slowly as tolerance to the
side effects develop.

The drug should not be

given intravenously or in a dose higher than 35 mg.
hypodermically if the patient is ambulatory.
In contrast to morphine, urinary retention

and respiratory depression occurred rarely with
Demerol.

'--'-'

Batterman (5} found the latter effect in

2 patients of 774 receiving the drug parenterally.

In both instances the respir~tory depression was
of short duration and responded readily to the
usual stimulants.
Batterman (5) also 1·ound that conist1patio;i,
which occurs in practically every patient treated
with opiates, never resulted from medication w1tn

Demerol.

'-,.

'-'
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~
THERAPB..1JTICS

In the realm of therapeutics, we find that
Demerol possesses three main actions: analgesia,
spasmolysis and sedation.

The relative analgesic

effect es compared with codeine and morphine can
be demonstrated by the method of Hardy, Wolff and
Goodell (17).

The administration of 100 mg. of

Demerol orally results in the elevation of the
peripheral pain threshold within fifteen minutes,
reaches a peak of approximately 50 per cent at the
end of one hour and gradually subsides in about
six hours.

'--

Intramuscularly the effect appears

within ten minutes, reaches its peak in forty-five
minutes and persists for several hours.

By this

method 5U mg. of Demerol intramuscularly was
found to be approximately twice as potent as 22 mg.
of codeine.

Similarly, 125 mg. of Demerol approach-

es the effectiveness of 17 mgw of morphine but does
not persist as long.
Demerol administered intramuscularly in a
single dose of 100 mg. will allow the subject to
experience approximately 80 per cent more pain
than during the control period.

This elevation

of pain threshold approaches closely that obtain-

~
16

~

ed with 15 mg. of morphine but appears more quickly, usually reaches its peak within 45 minutes and
subsides sooner.

In actual use for the relief of

pain, analgesia occurs within 15 minutes by the
parenteral route, within ~o to 60 minutes by the
oral route and usually subsides in the average
patient within ~-4 hours.

Analgesia does not per-

sist as long as in the case of morphine, and for
this reason, if the pain is severe or chronic,
Demerol must be administered at more frequent intervals.

In contrast, however, to morphine it

possesses little danger of cumulation of undesir-

'---

able effects such as respiratory depression, deep
narcosis, urinary retention or constipation, and
therefore may be used with a greater degree of
freedom and safety.

Moderately intense pain can

be controlled with 50 to 100 mg. every 4 hours.
With severe pain as much as 150 mg. may be given

every 3 hours.

It is rarely necessary to exceed

this dose to achieve a satisfactory relief of
pain.

If the patient does not respond to this

dose it is unlikely that a higher dose

or

Demerol

or a comparable dose of morphine will be more
effective.

uccasionally a patient will stop re-

~
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sponding to an analgetic not because of tolerance,
but because the pain is so severe that any dose

short of one resulting in mark~d cerebral depression would be ineffective.

In such a case it

is advisable to resort to other analgetic procedures such as nerve block or section.
The practical use 01· this effect in man has
been applied to the relief of pa1n due tu a large
variety of conditions.

The duration of analgesia

is about three hours.

Visceral pain such as that

arising from the peritoneum, pleura or smooth
muscle is relieved more effectively than pain aris-

'--'

ing from skeletal and neurologic structures.
Demerol administered parenterally is at least
as effective as morphine in producing clinical
analgesia.

Comparative studies on the same patient

would indicate that 100 mg~ of Demerol parenterally
in equivalent to 10 mg. of morphine.

Oral admin-

istration of Demerol is less satisfactory than
parenteral administration,
variations in absorption.

perhaps because of
Nevertheless the oral

route is useful and y1elds satisfactory results.

In connection with adm1n1s~ration of the drug,
Hoffman (2~) concludes ai·ter fifteen months obser-

~
18
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vation that the oral administration should be
used to keep the pain threshold at a high level.

But to relieve severe pain the injectable method
should be used.

The latter acts very promptly--

much more rapidly than morphl.ne.
The second important action of Demerol is
its general spasmolytic effect in man.

Intuba-

tion studies have demonstrated this action on the
stomach, pylorus and small and large intestine of
human subjects. The effect is due to an atrop1nelike action on the parasympathetic nerve endings
and a papaverine-like direct depression of smooth

'--

muscle.

In direct contrast to the action of

opiates (morphine), the motility

or

the intestine

is so influenced that tne segmental contractions
and tone are diminished or abolished, while propulsive action is unaltered.

Clinically this

action 1s manifested by the rapid and often dramatic relief of colicky pain.

Prolonged use ot

the drug in therapeutic doses does not result in
constipation.

Hence, Demerol is of little value

1n the treatment of diarrhea and cannot replace

opiates for this purpose.

Thus it would appoar

tllat Demerol has defin1te spasmolytic action in

~
19

~
man.

In contrast to the effect of morphine, and
antispasmodic response on the intact ureter by
Demerol has been demonstrated 1n animals and man
by Climenko and Berg (10).

The relief to patients

with renal and ureteral colic 1s thus explained by

experimental evidence.
The third action of Demerol to be considered

1s sedation.

'l'his usually occurs with the larger

parenteral doses, r·esulting in sleep from which
the subject can be aroused easily.

It usually

subsides within two hours, but when the drug is

'--

given at night or to pati~nts who have been sle~pless because 01· pain the sleep may last longer.
~atients note no after-reactions or mental confusion on awakening.

Ambulatory patients may com-

plain of drows1ness at first, but tolerance ls de-

veloped to the sedative effect.

In contrast to

morphine, excitation is rarely 1f ever observed
w1'th Demerol.

"'
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THE USE OF DEMEROL IN ANESTHESIA
Several of these properties attributed to
Demerol caused attention to be focused upon its
use 1n cl1n1ea.l anesthesia.

Its hypnotic effect

would serve to produce tne psychic depression desirable for patients submitting to anes~hesia.
Its drying effect on secretions (atropine-like)
would be of definite advantage.

The analgesic

effects would serve to eliminate pain preoperat1vely and diminish it postoperatively.

The

absence of appreciable respiratory depression
would eliminate one or the most serious objections

"-

to morphine.

The absence of untoward effects up-

on circulation and renal function would be welcome and the maintenance of normal pupi~lary reactions might aid in determining readily the degree of narcosis when inhalation agents were employed.

Its reported negative effect upon meta-

bolic rate might be considered as unfavorable.
Preanesthetic medication serves one of its most
useful purposes in reducing metabolic activity.
With this in mind Rovenstine and Batterman
(26) observed the effects on a series of 12 dogs
~hen Demerol was given prior to anesthesia.

'--

'-'
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The

~
dogs were anesthetized by means of cyclopropane,
ether and pentothal sodium.

The results for each

group of 4 dogs with a comparison of the findings
with and without premed1cat1on were recorded. The
results were similar to those noted when morphine
was the preanestnetic agent.

With Demerol, as in

the case of morphine, the amount

or

inAa.lation

agent required to secure a certain degree of
anesthes1a was reduced and ~ne ertectiveness

or

a given amount of pentothal sodium was prolonged.
other observations during these studies revealed that (1) the animals exhibited mild ex-

"-

citement characterized by restlessness,. hyperpnea
and tachvcardia twenty to thirty seconds after
the intravenous injection of Demerol.

This ex-

citement stage resembled that seen in dogs after
morphine is injected intravenously, but was less
severe and not as persistent, usually subsiding
within one minute.

(2)

It was possible to insert

an endotracheal airway within two to four minutes
in animals given Demerol.

On the other hand, in

the same animals without premedication, intubation
could not be carried out conveniently in less than
five to eleven minutes.

(3)

"''-'
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These untrained

~
animals exhibited no excitement during induction

of anesthesia after Demerol was given. (4) Mucous
secretions were not increased when anesthesia was
induced after the dogs had received Demerol. (5)
Although the pupils became pinpoint after administration of Demerol, the movements of the eyeball
remained active. (6)

The respiratory rate return-

ed to normal following the short period of hyperpnea in the initial excitement stage.

From these few observations, favorable for the
use of Demerol as a preanesthetic agent in dogs,
its use in man for this purpose appeared warranted.

~

In a group of 338 unselected consecutive
patients, both male and female, ranging in age from
15 to 89 years of age, Demerol was used for pre-

anesthetic medication.

Demerol was given in doses

of 50, 75 and 100 mg., and when combined with
scopolamine the amounts of the latter were 0.4,
0.5, and 0.6 mg. respectively.

A dose of 100 mg.

of Demerol was used whenever it was decided that
the patient would require 0.016 Gm.
of morphine.

(1/4 grain)

Similarly, 75 mgm. of Demerol was

used in place of 0.011 Gm. (1/6 grain) of morphine.

This ratio of the doses of the two drugs

'--
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was not altered for any patient.

For the Demerol-scopolamine combination regardless of the anesthetic used a satisfactory
response was obtained with 100 mg. of Demerol
hypodermically in 76 per cent of the 166 patients
treated, and undue depression was noted in 3 per
cent.

An

equivalent amount of morphine (0.016

Gm.} given to a corresponding number of patients
resulted in a satisfactory response in 81 per
cent and 1n deep depression in 9 per cent. Demerol,
given 1n doses smaller than 100 mg., produced
less favorable results except in the patients in

"-,

the age group over 60 years.

A satisfactory pre-

anesthetic state was recorded in 83 per cent of
the older patients receiving 75 mg., but this dose
was insufficient for 60 per cent of the patients

in the 20 to 60 age group.

Three of the 56

patients receiving 75 mg. were too depressed. One
of these was 62 years of age.
was likewise unsatisfactory.

true in those under 60 years.

The dose of 50 mg.
This was definitely
No

individual re-

ceiving this amount was thought to be 'too depressed.'

In 4 patients, aged 63 to 69, the re-

sults were satisfactory but more than half of
'-,,
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those between 15 and 60 years of age were apprehensive or the drug appeared to have little or
no effect.
The optimal time that should elapse after
Demerol and scopolamine are administered before
anesthesia is begun was found to be between fortyfive and ninety minutes.

A

satisfactory pre-

anesthetic state was recorded in approximately
89 per cent of the patients when this period of

time was allowed to elapse.

On the other hand, if

this interval was twenty to forty-five minutes,
and when the period was more than ninety minutes,

'\.,

the response was satisfactory in only 5 per cent.
All of the group recorded as •too depressed• had
received the drug more than forty-five minutes previously.
Those patients with satisfactory preanesthet1c
medication were usually breathing quietly at a rate
varying from 18 to 24 per minute.

11lle blood pres-

sure recorded during anesthesia compared with that
taken during the physical examination was not
significantly different in ?O per cent of the
patients.

It was increased in 20 per cent and de-

creased in 10 per cent.

.._,
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No extreme changes were

~
noted.

The changes in pulse rate were not signifi-

cant although it was usually increased slightly.
Demerol was given as the only preanesthetic
drug in a group of patients with results similar
to those observed when the drug was combined with
scopolamine.

The effects on respiratory rate

were not significantly different.

Mucous secre-

tions were definitely less when Demerol was used
than when morphine alone was given for preanesthetic medication.
Demerol's ability to dry secretions is more
effective than morphine.

~

In a group of patients

a majority complained of thirst or dryness of the
mouth after administration of Demerol and acopolamine.

This makes Demerol particularly valuable

in surgery of the mouth and throat in which analgesia and control of the salivary flow are desired.

In addition it is of interest to note

that in man Demerol has little if any sedative effect on cough, although because of its atropinelike action an occasional patient may be benefited by its decreasing the bronchial secretions.
Of particular advantage in the use of Demerol
hydrochloride as a preanesthetic analgesic agent

'-
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is the fact that unlike morphine the size of the

pupil remains unchanged and the pupillary reflexes
are easily elicited.

However, the corneal reflex

and sensitivity of the cornea are abolished in
about 80 per cent of the patients~
Inhalation anesthesia was induced with nitrous
oxide-oxygen, nitrous oxide-oxygen-ether; ether;
vinethene and cyclopropane.

In the group adjudged

to have a satisfactory effect the induction was re1.;orded as entirely uneventi'ul in 50 per cent of
those receiving nitrous oxide-oxygen or nitrous
oxide-oxygen-ether, while in 35 per cent there was

'\.,

some excitement (15 per cent slight, 14 per cent
moderate, 5 per cent severe) and in 17 per cent
laryngospasm occurred (none severe).

In those

receiving vinethene the results were approximately the same.

When cyclopropane was used induction

was uneventful 1n 82 per cent, and of those having excitement none was severe and in only one
was laryngospasm recorded*

Mucous secretions did

not interfere with the induction 1n any of these
patients.,

For comparison another group of patients were
given morphine and scopolamine for preanesthetic
'-,.
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medication and were anesthetized with nitrous
oxide-oxygen-ether.

Induction of anesthesia was

entirely uneventful in 64 per cent, there was excitement in 26 per cent (8.5 per cent moderate,
7 per cent severe) and in 19 per cent laryngospasm
occurred (2 per cent severe).
in 3 per cent.

Nausea was observed

The induction of cyclopropane

anesthesia a.f'ter morphine anesthesia after morphine scopolamine premedica~ion in 100 patients
chosen for comparison was uneventful 1n 84 per
cent.
Demerol and scopolamine were given a group

"~

of 25 patients who received spinal anesthesia. Tb.e
effect was satisfactory for 21, one was apprehensive and 3 were not sufficiently depressed.

Re-

gional anesthesia was employed for 16 patients who
received similar premedication, with good results
in 13 and apprehension recorded in 3.
Recovery from anesthesia was similar in Demerol
and morphine.

Such complications as hemorrhage,

shock, and abnormal reflex activity during operation after Demerol had been given were no different
than would be anticipated if morphine had been
use~ as far as the reaction of the patient and

'--
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response to treatment was concerned.
THE USE OF DEMEROL FOLLOWING SURGERY
In evaluating the effectiveness of Demerol
in surgery and medicine several factors were
taken into consideration.

It must be empha-

sized that one is dealing with a symptomatic measure and not a specific cure.

An

analgesic agent

offers only a means of controlling the pain, thus
making the patient comfortable while the specific
cause of his complaints is discovered and eradicated.

Thi.s aspect is often overlooked, and when

assessing an analgesic drug one finds, particular·~

ly if the medication is given only occasionally,
that the patient may continue to have pain.

On

close questioning, however, one may discover that
there was complete relief of pain for the duration of the drug's action, but when the effect is
dissipated, the patient considers himself unrelieved.
According to some investigators Demerol has
its greatest usefulness in the postoperative relief of pain.

Regardless of the severity of the

condition, the underlying disease, the ultimate
P.rognosis or the type of operation performed, the

'--'-'
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administration of 75 to 100 mg. every 3 to 4
hours during the immediate postoperative period
will be sufficient to make the patient comfortable,
reduce any restlessness and facilitate the usual
postoperative procedures.

For this purpose

Demerol is superior to morphine because it rarely
results in deep narcosis, respiratory depression
or urinary retention.

The cough reflex is unalter-

ed so that expectoration is not interfered with as
in the case of morphine, thus elimination an important contributing factor for pulmonary compli-

~

cations.
The immediate relief of restlessness, the
rapidity with which the patient becomes comfortable and the minimal distress produced by the usual postoperative therapeutic procedures are all
striking objective evidence for the effectiveness
of Demerol under such circwnstances.

U

pain or

discomfort persists for more than 48 hours, satisfactory relief can subsequently be obtained with
the orally administered preparation.
The effectiveness of Demerol immediately becomes apparent when its ability to control postop.. erative pain is observed.
'-a..
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In a group of 164

~
patients, reported by Batterman and Mulholland
(7), receiving the drug parenterally during
the postoperative period af'ter laparotomy 95.5
per cent of the 182 trials resulted to complete,
satisfactory relief of the pain, discomfort and
restlessness.

After procedures other than lapa-

rotomy Demerol is only slightly less effective.
Thus in 91.5 per cent of 271 trials in 252 cases,
postoperative pain was completely controlled. An
additional 5.2 per cent experienced a moderate
effect, or relief for approximately three hours.
Batterman (5) reported that the postoperative

~

course following surgical procedures such as laparotomy, thyroidectomy, mastectomy and herniorrhaphy
is very well controlled with a minimum of untoward

reaction.

The immediate relief of restlessness,

the rapid establishment of the patient's comfort,
and the minimal distress produced by the unusual
postoperative therapeutic procedures are all striking objective evidence of the effectiveness of
Demerol hydrochloride in such cases.
It is well known that after-effects of rectal
operations are notoriously painful, occasionally
-necessitating the use of large doses of opiates.

'--
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In a group of patients there was failure to give
a satisfactory response to Demerol in only 4 instances out of 45 trials, and even in the 4
patients who failed to respond in one trial the
subsequent administration of a larger dose resulted in alleviation of the pain.

However, postopera-

tive control of pain was hitherto achieved only by
the use of morphine or one of its derivatives.

In the postoperative phase of treatment Demerol
was found to be a safe drug, rarely causing untoward
reactions.

The subjective responses of dizziness

and nausea occurred rarely.

~

Here again the anes-

thetic may have influenced the incidence of untoward
reactions.

The incidence of vomiting was no higher

than one would expect after major operations.
Since Demerol has been in use in surgery there has
been no instance of respiratory depression in a
postoperative patient.

Here obviously is a dis-

tinct advantage over morphine, for res1;iratory depression resulting from. frequent and repeated use
of morphine is a cause for grave concern.

With

several patients who had received mory;hine and in
whom respiratory depression had developed, it was
poss~ble to continue the administration of Demerol

""'-'
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for the control of pain without producing this
serious side effect.
Of postoperative complications, urinary retention may be most troublesome.

Catherization,

especially if repeated at frequent intervals, may
result in cystitis or pyelonephritis.

The inci-

dence of catheterization among consecutive postoperative patients receiving morphine was determined for a period of ten months.

During this

period 160 operations were performed; 20 patients,
an incidence of 12.5 per cent, required catheterization within twenty-four to forty-eight hours

~

postoperatively •

.Another group in th~ following

eleven months, in which Demerol was used exclusively, there were 178 consecutive postoperative
patients, of whom 14, or 7.8 per cent, required
catheterization.

There is no doubt that the type

of surgical procedure plays a significant role in
the development of urinary retention end must be
considered in an evaluation of the results just
cited.

The majority of the patients who were

catheterized,whether they received morphine or
Demerol, had had a rectal operation, a herniorrhaphy
or an op__eration on the lower part of' the abdomen.

"~
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Although the number of postoperative patients is
too small and the difference in incidence of
urinary retention between patients given morphine and those given Demerol may not be statistically significant, Batterman and Mulholland believe that Demerol is less likely to produce this
undesirable complication.
The only disadvantage of Demerol as far as
postoperative use is concerned is its short action.

This, however, is rarely apparent in the first
postoperative day.

For patients with a protracted

and •stormy' course the average dose may be suf-

~

ficient for only two hours.

r.rhis may be overcome

either by administering the same dose more frequ,antly or by increasing the dose.

There is no

particular danger of causing undue depression in
such cases.

'

'-if
34

~
DEMEROL IN MINOR £ND NON-OPERABLE CONDITIONS
Minor surgical procedures such as dressings,
application of casts, small incisions and drainages, thoracentesis, paracentesis and bladder
irrigations may be performed with greater ease
and with less pain if 75 to 100 mg. of Demerol are
given intramuscularly one-half hour previously.
According to Hoffman (21) thoracentesis was relatively painless in three cases, without employment of local anesthesia.

The same was true in

seven spinal punctures.

'-'

Following the administration of Demerol,
cystoscopic examinations and bladder irrigations
may be accomplished with greater ease and less
discomf'ort to the patient.

A group of 14 patients

were subjected to a cystoscopic examination and
had a catheter placed in the ureter with its tip
immediately above the ureterovesical orifice.

Em-

ploying the procedure described by Trattner in conjuction with highly sensitive photoelectric recording device normally occurring contractions were recorded for a period of fifteen minutes, after
which 75 mg. of Demerol were injected intramuscularly. Within from 2 to 20 minutes there was

' '-"
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diminution in tonus associated with a marked decrease in the amplitude of contractions·.

In most

instances the rate at which contractions occurred
was not seriously affected, but the intensity was
markedly diminished.

This spasmolytic action of

Demerol hydrochloride on the ureter is most marked in those instances where the ureter is in a
state of heightened tonus.
In the treatment or non-operative surgical

conditions the parenteral use of Demerol was
found to be effective for skeletal pain associated

"-'

with fractures and mete.static malignant growths,
arterial occlusions, impending gangrene,
thrombophlebitis, pleuritic pain of fractured ribs,
cellulitis, abscesses, carbuncles, burns, and nonspecific pain associated with various malignant
growths.

The severe pain of malignancies or chron-

ic hopeless diseases has always been a problem for
analgesia.

With Demerol several disadvantages of

morphine are circumvented.

Demerol may be used

relatively freely with little if any occurrence of
general tolerance to the analgetic effects.

'
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DEMEROL IN MEDICINE
Demerol relaxes effectively the smooth muscle
of the gastrointestinal tract, urinary bladder,
uterus and bronchi, thus resembling both atropine and papaverine.

Its action upon the gut is

unique. It inhibits segmental peristalsis, but
actually seems to activate propulsive peristalsis.
Patients on regular daily dosage frequently are
awakened in the morning by sensations denoting
the necessity of innnediate bowel evacuation. Instead of diarrhea following, there is likely to

~

be no bowel evacuation until the following morning, when the propulsive action recurs.

Demerol

was used in a small number of cases of colicky enteritis, stopping the incessant cramps out the
bowel emptied effectively daily.

Hoffman (22)

reports that in four cases of suspected appendicitis and one of ruptured duodenal ulcer Demerol
relieved pain, but in no manner masked diagnostic
signs.
Hoffman (22) also has found the drug quite
effective in relieving angina pectoris.

However,

on account of its action on the vagus nerve it
seems ~ise to employ it cautiously in degenerative

'
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heart disorders.
Because of the antispasmodic action of Demerol
it is of definite value for the treatment of acute
and chronic asthmatic conditions.

It is a well

known fact that morphine is contraindicated for
such patients.

Twenty-five or 35 mg. subcutaneous-

ly, a dose much lower than that required for
either analgesia or sedation, will relieve the
average patient with an acute asthmatic attack within 10 minutes.

Where sedation is also desired

as much as 100 mg. may be given every 3 hours.
There is little danger of respiratory depression.

~

The rapidity and duration of action as well as
the degree of reaction 1s not as great as with
epinephrine.

The oral route is not very effective

for the acute attack because of the delayed response, but it is of undoubted value in chronic
asthmatic conditions, particularly those associated
with bronchitis.

With an appropriate dose, individ-

ually determined for each patient, administered
several times daily and before retiring, it is
possible to decrease the number and severity of the
attacks.

Demerol is purely a symptomatic measure

and does not alter in any way the course of the
~
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disease.

With acute respiratory infections,

the asthma may become so severe that only
epinephrine or aminophylline (parenteral) is
effective.

However, when the acute phase sub-

sides Demerol is again helpful.

Many patients

prefer it to ephedrine since it is taken constantly for several months. An occasional patient
is not benefited because the atropine-like effect
of drying the secretions may temporarily aggravate
the condition.
.Ambulatory asthmatic patients have fewer and
less severe attacks when Demerol is administered

~

every four hours.

An acute attack of asthma can

be relieved within 10 minutes by the subcutaneous
injection of 35 mg., a dose far below that required to produce analgesia or sedation.

The bron-

chial relaxation is less than that achieved with
epinephrine.

Nevertheless Demerol probably has a

theoretical advantage as an antiasthamatic agent,
since it would tend to reduce the autonomic reactions usually associated with a severe attack.
Epinephrine would heighten the fear component even
though the asthma was relieved.

Good results have

been obtained with a mixture consisting of 35 mg.

.._,
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of Demerol and half the usual amount of epinephrine.
Demerol also affords good relief in pleuritic
and arthritic pain regardless of causation.

For

the severe pain of myocardial infarction, it may
be necessary to repeat the dose within one hour.
As in the case of morphine a patient in severe pain
may tolerate very large doses.

The dangers of

overdosage, however, are much less with Demerol.
Hoffman (21) reported six cases of the general
arthritic group, who had been compelled to lay off
work from time to time.

After taking an average

of two tablets daily, by mouth, and 0.5 cc. of

~

Demerol intramuscularly about twice weekly they
have novv remained at work regularly for three months.
Salicyla.tes were acided after each had had a successful trial of three weeks on Demerol alone •

Pruritus, a symptom closely related to pain,
may be successfully alleviated with Demerol.

This

is in contrast to morphine which commonly produces
pruritus and is therefore contraindicated for most
skin diseases.

Patients with chronic eczema in

particular are made more comfortable with Demerol
so that the decreased scratching contributes to the
quicker response of appropriate ointments.
~...,,,,,,,
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Demerol has been used successfully in alleviating the reactions to fever therapy, particularly those associated with the rapid method of
antisyphilitic therapy.

If 150 mg. are admin-

istered shortly before or simultaneously with the
mapharsen-typhoid injection and repeated at the
height of the fever, the patient will be relatively free of the more severe reactions and
usually will remain asleep throughout the period
of therapy.

DEMEROL IN NEUROLOGICAL CASES
Chronic nerve pains such as neuritis, radi-

~

culitis, the shooting pains of tabes dorsalis,
intercostal neuralgias following thoracoplasty,
have been always difficult to treat and are not
satisfactorily relieved with the opiates.

For

such cases Demerol is superior to morphine.
Satisfactory results were also obtained in
treatment of pain in neurologic conditions such
as sciatica, cardiovascular pain, such as severe
anginal syndrome and distress of congestive failure; and visceral or colicky pain of biliary, renal and gastrointestinal origin.
A small group of patients with 'slipped'
'-,
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intervertebral discs, complicated by sciatic
neuralgia, were able to resume their work for
about two weeks, until arrangements were made for
surgical removal of the discs.

They had an aver-

age of 1.5 cc. Demerol injected daily (given
morning and evening) while at work.
Two cases of unrelieved intense localized
pain along the spine have been reported by Hoffman
(21), following classical spinal fusions performed in the hope of relief, were kept sufficiently
free from pain for five months to permit their regular employment.

"-'

Neither was wholly freed of

pain, but pain previously unbearable was diminished enough to prepare each for additional surgery.
Demerol proved to be effective as a reliever
of pain from faulty skeletal structure, especially
of the spine.

A group of 'backs' were treated in-

cluding old vertebral body, body fractures, ruptured intervertebral discs, spondylolisthesis, spinal
fusions with complications, and hypertrophic
spondylitis.

Many of these had •trigger spots' of

excruciating pain.

Slightly less than half of the

latter, when their muscle spasms were held in
check for a fortnight by Demerol, required no
'~
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correctional treatment by braces or by operation.
Such temporary improvement is not cited as a
•cure•.
Root pains, resulting from tabes dorsails,
have been greatly relieved by the administration
of Demerol.

One man who had been unable to keep

a steady job during the previous year due to unpredictable 'lightning' pains, enjoyed three
months of continuous employment by reporting for
injection as soon as the pain appeared.

On six

different occasions he was able to return to his
work within a half hour following the injection.

~

The need for getting patients back to their jobs
quickly calls for the rapidly effective injected
drug rather than orally administered.
Fitzgerald and McArdle (14) reported a series
of 12 neurological cases in which Demerol was
found to have effects comparable with, and in
some cases superior to, morphine.

With morphine

all received considerable relief, but it was less
definite and of a shorter duration than that following Demerol.

The group of patients included;

radial neuritis with fibrosis, brachial neuritis,
supraorbital neuralgia, trigeminal neuralgia,

~
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sciatica, thalamic syndrome, tabetic crisis,
Gasserian gangalion injection for tic douloureux,
lumbar puncture headache, and encephalographic
headache.

When the drug was given intravenously

it occasionally produced objectionable side-effects
ranging from transient giddiness lasting a few minutes to giddiness, pallor, syncope, sweating, and
nausea persisting for about one-half hour.
DEMEROL IN OBSTETRICS
It is felt by several investigators that
Demerol is fast becoming a safe and effective
means of medicating full-term patients during

"-'

labor, while the absence of serious respiratory
depression in the newborn makes this type of analgesia particularly suitable in obstetrics. According to Stander (28) morphine is not an ideal
analgesic in labor and its use will eventually be
restricted to a small group of neurotic patients
upon whom it is desirable to exert a psychic
effect.

In addition, several serious objections

are inherent to this form of analgesia.

In the

first place, it results in a definite prolongation of the second stage, necessitating more frequent instrumental interference, with its addi-

~
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tional danger of infection.

In the second place,

it is attended by a definite, but slight, increase
in the fetal mortality, estimated at between 1 and

2 per cent, which is apparently due to direct
poisoning of the fetus.

A large proportion of the

children are born in a apneic condition: a smaller
number are deeply asphyxiated, but can be resuscitated without great difficulty; while occasionally the asphyxia is so deep that resuscitation 1s impossible.
Demerol is being used for analgesia in obstetrics in 1Lany inf.:ti tutions with uniformly good

~

results.

Once labor is well established, the ad-

ministration of 150 mg. intramuscularly immediately alleviates the restlessness and the severe pain
without interfering with the course of labor.

If

anything, the first stage appears to be accelerated.

The mother usually rests well between con-

tractions, can easily be aroused for questioning
or given supportive therapy without difficulty. A
second dose of 100 to 150 mg. may be given within
three hours, but it should not be repeated if delivery is expected shortly thereafter.

The major-

ity of patients require no more than 2 doses.

~
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If
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labor is prolonged, however, 100 mg. may be given
every 3 hours.

Although Demerol may be used in

conjection with scopolamine or barbiturates, their
use 1s not absolutely necessary.

The fetus is us-

ually born in good condition and the incidence of
depression is not greater than what one would expect from the course of the labor, complication
and the general anesthetic used during the second
stage.

Blood loss is not excessive and the fundus

contracts down properly with oxytocics.
Roby and Schumann (25) studied the effect of

~

Demerol with scopolamine in labo~ Preliminary
trials indicated that oral administration was ineffective in the parturient patient.

Consequently,

when the patient began to complain of her pains,
regardless of the state of dilatation of the cervix,
she received 100 mg. of Demerol intramuscularly
and sco~olamine gr. 1/100 subcutaneously followed
by scopolamine gr. 1/200 in one hour.

This was

sufficient to maintain the multiparous patient
throughout the balance of her labor, while primiparas required additional medication in the form
of scopolamine gr. 1/200 every one to five hours.
S~tisfactory amnesia was obtained in 95 of

~
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112 patients.

The possibility of prolonging labor

by the use of Demerol and scopolamine was not
apparent.

The condition of the patients, re-

ceiving the medication

was, in general, favorable.

The incidence of vomiting of other undesirable
effects was no greater than when other types of
medications were used.

A few patients complained

of dizziness but attending euphoria was not present.

The majority of the patients were conscious

enough to be cooperative and restlessness was
kept at a minimum by infrequent administration of
scopolamine.

'--

Demerol and scopolamine were used in a series
of 1,000 cases by Schauman (27) for the purpose
of studying the maternal and fetal effects of this
combination when used as an obstetrical analgesic.
Demerol was used to obtain psychic sedation
through its analgesic effect, thereby securing a
favorable background for the action of scopolamine, reducing the excitement, and enhancing
amnesia.

A routine of medication was adopted us-

ing initially Demerol 100 mg. and scopolamine gr.
1/100 intramuscularly. Subsequently, Demerol 100

mg. and scopolamine 1/200 was given intraven\~
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ously every 4 hours.

New admissions, expected to

deliver within 2 hours, were given Demerol 50 mg.
and scor-iolamine 1/200 by slow intravenous injection, using a minimum of 2 minutes for 2 cc.
{100 mg.).
Satisfactory amnesia was obtained in 70.5 per
cent of 847 cases.

The remaining patients who had

analgesia but no amnesia or failure of analgesia
and amnesia, may have received the medication too
late to benefit materially from its effects, while
a few had not been medicated as frequently as called for in the routine.

'--'

If the fault in these

cases be thought to lie in the administration
rather than the drug itself, then 9.6 per cent of
the entire group may be discredited.

The average

primiparous labor in this series was 12.4 hours,
the average multiparous labor, 7.6 hours.

This

is a reduction in the length 0£ labor of approximately 15 per cent as compared with a group of
patients who received barbiturate analgesia. The
only maternal untoward effects in the series were
seen in the intravenous group.

With the exception

of transient nausea in one-fourth of the cases, no
further side effects were seen when the drug was

"-'
48

~

administered slowly.
The newborn infant breathed spontaneously in
82 per cent of the cases.

In another 12 per cent,

the infant respired within 2 minutes upon administration of oxygen; all babies were eventually
discharged as normal •
ttealizing that any depressant action of obstetrical analgesia on the newborn would be maximal in the premature group, an analysis was made
of the premature infants in a series of cases.
It was observed that not only were 91.0 per cent

"-

of the prematures in satisfactory condition on
leaving the delivery room but also that there is
no correlation between the weight of the baby and
the degree of respiratory depression.

There is

little to suggest a respiratory depressant effect
in this group.

Demerol exerts no demonstrable de-

pressant effect on either full-term or premature
infants, whether administered by the intramuscular
or the intravenous route.
In view of the satisfactory amnesia, the absence of pulmonary complications, and the freedom
from depressant effect on the fetus, it is the

.

opinion or Schauman (27) that Demerol in conjunc-
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tion with scopolamine is superior as an obstetrical analgesic to other analgesics in common use.
Gilbert and Dixon (15) studied the use of
Demerol as an obstetric analgesic in 150 women.
In 70 cases. Demerol was used alone and in 80 cases
in combination with other drugs.

Intramuscular in-

jections were given the majority of the patients
because of greater uniformity and rapidity of
effect when so given.

In 54 primipara patients an average dose of
294 mg. of Demerol was administered; the average

total length of labor was eleven hours and eighteen

""

minutes.

When seconal was combined with Demerol

the results were substantially the same.

In 16

multipara patients, receiving Demerol alone, the
average length of labor was nine hours and four
minutes and in 10 cases receiving Demerol and
secpnal the average length of labor was six hours
and six minutes.

It seems likely that in anal-

gesia of multipara patients Demerol alone may
prove to be particularly suitable, since often
the institution of a major amnesic regime to carry
such cases through and ease labor seems scarcely
warranted.

~
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With experience limited to only 150 cases,
conclusion as to the effect on length of labor
must be tentative, but it appears that shortening
of labor occurs when Demerol is given.

This may

be result of the drug's spasmolytic effect acting upon the cervix, or may simply result because
the patient bears down more vigorously when the
pain threshold is raised.

Doses of 100 tnga of

Demerol even when given at onset with the cervix
not effaced, will not stop labor or diminish the
effectiveness of mild contractions.
Of the 70 patients receiving Demerol alone,

'\.,

adequate analgesia without amnesia was found in
72 per cent.

of the 72 patients receiving Demerol

and seconal, 61 per cent of the patients obtained
satisfactory amnesia.

The poor statistical re-

sults was due to inadequate doses of seconal (1½
to 3 gr.).

While an occasional case would obtain

satisfactory amnesia with this low hypnotic dosage,
particularly after fairly large amounts of Demerol
had been given, less than 4½ gr. of seconal were
uncertain.

Demerol does potentiate the action of

seconal enough to reduce significantly the amount
of this hypnotic necessary to obtain amnesia in

"--'-1
51

"-'

the labor patient.

With proper utilization of

seconal in a patient adequately prepared with
Demerol, amnesia can be obtained consistently witn
smaller doses of the barbiturate than can be used
successfully alone.
With large doses of Demerol (300 to 500 mg.)
a moderate sedative effect was noticed and women

would frequently sleep between pains.

This was

never so pronounced that the patient would not
awaken when spoken to in an ordinary conversational tone.

Ho excitement, disorientation, or ir-

rationality because of the drug was noticed in

~

patients under Demerol alone.

~omplaint

01'

dizzi-

ness aud light-headedness was occasionally noted
but was not prominent.

Complaint of thrist and

dryness of the mouth was frequent.

With patients

delivered under inhalation anesthesia, this depressed secretory activity in the nasopharynx
had an obvious advantage.

No post-partum de-

pression, confusion, or •hangover• as a result of
Demerol medication occurred.
third stage was seen.

No effect on the

Bleeding was not increased.

Of the 70 babies born to mothers when Demerol
alone was used, 66 breathed spontaneously.

'\_;
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No

~
babies showed any persistent cyanosis, ev1dence
of narcosis, or otherwise merited the term
•sleepy baby' where this is meant to describe drug effects.

Of the 80 babies born to

mothers when Demerol in combination with other
drugs was used, 69 breathed spontaneously and 10
breathed only after insufflation.

In the presence of apnea at birth, it is the
usual practice to allow ordinary methods of cutaneous stimulation only a brief trial, usually not
more than one minute, before resorting to 1nsuf-

'"'-'

flat1on to relieve anoxemia.

It cannot be denied

that the addition of barbiturates to Demerol analgesia has a slight to moderate depressant effect
on the baby, but in the dosages recommended it is
rarely of disturbing degree.

Fetal narcosis was

not a major factor in the apnea presented by
these babies~

All breathed and progressed nor-

mally after a brief period of artificial oxygenation.
The use of Demerol as recommended permits an
elastic type of obstetric care during labor. Uonduct of each case may be individualized in accord
with the character and rapidity of labor; the de-

'-'-'
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cision to institute amnesic therapy, with its
additional nursing responsibility and possible
risk to mother and baby, may be made relatively late, depending upon the reaction of each
patient to the stress of labor.

ADDICTION AND HABITUATION
With any drug possessing morphine-like
action on the central nervous system, serious
consideration must be given to questions concerning the possibility of addiction.

In the

pain free, normal subject, the effects of Demerol

~

are described variously, depending perhaps on the
underlying psychologic makeup of the individual.
In some the effect is pleasant, a sense of' wellbeing or euphoria; in others, there is a disagreeable sense of insecurity or the occurrence of unpleasant dreams.

Some subjects like the effect

and want to repeat it, while in others tne converse attitude occurs.

Since this may involve the

•nitritoid' reaction, the position of the patient
may influence the effect and subsequent use of
the drug.

The implications of the experience and

the personality makeup of the individual are obvious.

'-\.,
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Drug addiction is a condition 1n which a
person has lost the power of sel1' control relative to a drug.

When a regularly pleasant

effect leads to a strong desire for frequent repetition, psychic dependence or habituation is
likely to result.

extension of such frequent

An

and regular repetition of a drug as regards both
dosage and interval of administration may lead
to the development of physical dependence.
Physical dependence, a serious consequence of
morphine abuse, is perhaps related to overcompensation by the autonomic nervous system in order

~

to maintain homeostasis of certa1n vital functions
disturbed by the drug.

On discontinuation of" the

drug an abstinence syndrome cons1st1ng of characteristic signs and symptoms occurs.

While physi-

cal dependence on Demerol has not yet been encountered in

1 normal

1

persons, it has been pro-

duced in former addicts.

However, because of the

brief duration of the physical dependence action
of Demerol and its lesser potency than morphine
in this regard, the experimental production of
physical dependence on Demerol 1s not easy even of
such patients.

ltor example, habituation but not

~
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significant physical dependence resulted from the
administration o~ 75 mg. of Demerol four times a
day for a period of three months.

~or did clini-

cally significant physical dependence develop
when the drug was administered in amounts of 75
to 100 mg. eight times a day for four weeks to former addicts who had never before received Demerol.
However, those who had had previous experience
with Demerol developed definite physical dependence
to ~he latter dosage after two weeks of readministration.

~

On the other hand, when Demerol was

clinically read.ministered to patients who were not
former addicts, abstinence phenomena were not encountered on its subsequent discontinuation.
While the implication of these results is not yet
clear, they suggest that a somewhat different mechanism may be involved than that entailed in the
development of physical dependence to morphine.
Demerol may produce physical dependence, however, physical dependence is not likely to result
if the therapeutic requirement is not exceeded.
On the other hand, it is not uncommon to note the
development of physical dependence on morphine by
pat!ents requiring its use for a chronic ailment.

~
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~
Such patients are not usually considered addicts
in the sense that abuse of the drug is not an
outstanding feature.

Nevertheless, it is often

difficult to distinguish between the actual
necessity for morphine to alleviate the condition
or satisfy the physical dependence.

This experi-

ence agrees with the theoretical relationship to
the development of physical dependence of the relative potencies and the durations of action of
morphine and of Demerol, the latter being weaker
and shorter in its physical dependence action.

-~

If Demerol is abused by a former morphine
addict, physical dependence is apt to result. This
raises the question of whether or not the drug is
of any value in the treatment of the morphine abstinence syndrome.

Although it is conceded that

the best drug for this purpose is morphine itself,
Demerol also definitely modifies the syndrome and
can be used satisfactorily in place of morphine
for this purpose.

Its ameliorative action is con-

siderably briefer than that of morphine, and this
must be taken into account in prescribing a rapid
reduction treatment with the drug.

~
5?

Large frequent

'-'-I
doses are required when patients are being treated
who have shown a strong dependence on morphine.
For such patients Demerol is less satisfactory
than morphine.

Demerol is a satisfactory but it

must be emphasized, however, that if Demerol is
continued in the treatment of such patients, physical dependence may be shifted from morphine to
this drug.

Hence it is necessary to reduce the

dose progressively.

Furthermore, 'breaking the

habit' in an individual case while under observation does not constitute a

1

cure', since the psy-

chiatric make-up of the patient remains unaltered

~

and, unless corrected, drugs are resorted to again
on discharge.
Himmelsbach (19,20) of the United States Public
Health Service reported on thirteen morphine addicts
who received Demerol instead of morphine for a
period of ten days.

The results indicated that

Demerol only partially satisfied the physical dependence established to morphine.

The abstinence

syndrome following withdrawal not only was less
severe by objective criteria than that of morphine
or codeine, but the subjective complaints were
markedly reduced.

Some patients remarked that

~
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the effect of medication was similar to atropine
or hyoscine; the majority like the effects and
considered the substitute a "good treatment" .for
withdrawal.

In another experiment Demerol was

administered to 4 former addicts in progressively increasing amounts •

.An

average dose of 173

mg. was administered hypodermically at a mean interval of approximately 2¼ hours throughout each
twenty-four hours for a total of ten or eleven
weeks.

On withholding the drug for twenty-two

hours after one month of administration, mild
signs of abstinence appeared.

~

Nevertheless, the

patients complained of no appreciable subjective
discomfort.

Following ten of eleven weeks of

administration the drug was abruptly discontinued
and there occurred withdrawal symptoms, less
severe than those of morphine but of essentially
the same order as those of codeine.

It should be

emphasized that the subjects in this study received daily as much as ten times the therapeutic
dose of Demerol;

also, because of the brief dura-

tion of dependence on Demerol and its lesser
potency than morphine in this regard, the experimental production of physical dependence on

"-
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-Demerol

is not easy even for such patients. Wbile

the implication of these findings is not yet
clear, they suggest th~t a somewhat different
mechanism than that entailed in the development
of physical dependence to morphine may be involved.
Inasmuch as a euphoric reaction occasionally
follows the use of Demerol, it is logical to conclude that prolonged use in some individuals may
lead to the development of psychic dependence or
habituation.

The drug appears to possess a lesser

liability that morphine for the development of
physical dependence.

~

Clinical research on Demerol

indicates that when it is administered for relief
of pain in a.mounts not in excess of 150 mg. every
three hours, habituation and physical dependence
on the drug are not likely to occur.

However, the

medication should be used with caution inasmuch as
in the absence of pain, physical defendence has
been produced ex;e:'imentally in former or active
morphine addicts when daily aruou.nts in excess of
therapeutic dosages were administered for prolonged periods of time {upwards of 2 months).

'---.....,
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DEMEROL UNDER THE NARCOTIC LAW
Demerol was brought within the purview of the
federal narcotic laws by a law enacted by Congress
and approved by the President, July 1, 1944. All
manufacturers, wholesalers, retailers, and practitioners procuring, prescribing, or dispensing
Demerol, if not already registered, must register
in an appropriate class under the federal narcotic
law.

An inventory on appropriate forms of all

Demerol on hand before July 1, 1944 must be submitted to the collector of internal revenue before
September 1, 1944.

'-\..,

Manufacturers must tax stamp

each package before sale or removal. The effect
of this law is to subject the use of Demerol to
the same restrictions imposed on the use of narcotic drugs.

'--
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CONCLUSIONS

With the exception of cough and diarrhea,
Demerol has been found to be a satisfactory therapeutic substitute for morphine.

It appears to

possess the following clinical advantages over
morphine:
1.

Its spasmolytic action makes it ideal for the

relief of conditions due to smooth muscle spasem,
in which morphine is pharmacologically contraindicated.
2.

Its rapid dissipation tends to offset unde-

sirable cumulative effects such as respiratory

~

depression and urinary retention.
3.

Prolonged use of Demerol may lead to the de-

velopment of habituation, but it appears to possess a lesser liability than morphine for the development of physical dependence.
4.

It may be used without fear in patients with

severe anemia, disease of the liver or kidneys or
bronchial asthma.
5.

Demerol has proven to be a satisfactory ob-

stetrical analgesic.

There is an absence of pul-

monary complications and freedom from depressant
effect on the fetus.

Satisfactory amnesia is ob-

"-'
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~
tained and labor may be shortened by its use.
6.

As a pre-anesthetic analgesic, Demerol pre-

sents the following advantages:

Has fewer un-

favorable side effects such as nausea, vertigo;
will not depress respirations or other vital
functions; and is more effective in drying secretions than morphine.

~

~
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